BIOMAT Database Logo BIOMAT Database Logo

Hyperthermic isolated perfusion with melphalan in the treatment of advanced malignant melanoma of the lower limb. 1990

A I Skene, and A S Bulman, and T R Williams, and J M Thomas, and G Westbury
Department of Academic Surgery, Royal Marsden Hospital, London, UK.

A retrospective study of 91 patients with malignant melanoma treated by lower limb isolated hyperthermic regional perfusion was performed. Objective response in patients with evaluable disease was 78 per cent. The role of perfusion as primary treatment of large melanomas of the foot is confirmed and recommended. Control of locoregional disease and limb salvage remains a valuable and attainable therapeutic goal using this technique.

UI MeSH Term Description Entries
D006979 Hyperthermia, Induced Abnormally high temperature intentionally induced in living things regionally or whole body. It is most often induced by radiation (heat waves, infra-red), ultrasound, or drugs. Fever Therapy,Hyperthermia, Local,Hyperthermia, Therapeutic,Thermotherapy,Induced Hyperthermia,Therapeutic Hyperthermia,Therapy, Fever,Local Hyperthermia
D007866 Leg The inferior part of the lower extremity between the KNEE and the ANKLE. Legs
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D008558 Melphalan An alkylating nitrogen mustard that is used as an antineoplastic in the form of the levo isomer - MELPHALAN, the racemic mixture - MERPHALAN, and the dextro isomer - MEDPHALAN; toxic to bone marrow, but little vesicant action; potential carcinogen. Medphalan,Merphalan,Phenylalanine Mustard,Sarcolysine,Sarkolysin,4-(Bis(2-chloroethyl)amino)phenylalanine,Alkeran,L-PAM,Mustard, Phenylalanine
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010478 Chemotherapy, Cancer, Regional Perfusion Neoplasm drug therapy involving an extracorporeal circuit with temporary exclusion of the tumor-bearing area from the general circulation during which high concentrations of the drug are perfused to the isolated part. Cancer Chemotherapy, Regional Perfusion,Perfusion Cancer Chemotherapy, Regional,Regional Perfusion Antineoplastic Chemotherapy,Isolation Perfusion Cancer Chemotherapy,Regional Perfusion Cancer Chemotherapy
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012189 Retrospective Studies Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons. Retrospective Study,Studies, Retrospective,Study, Retrospective

Related Publications

A I Skene, and A S Bulman, and T R Williams, and J M Thomas, and G Westbury
Isolated hyperthermic perfusion with mitoxantrone of melphalan in malignant melanoma of the limb.
October 1995, American journal of surgery,
A I Skene, and A S Bulman, and T R Williams, and J M Thomas, and G Westbury
[Isolated hyperthermic limb perfusion with melphalan and tumor necrosis factor in malignant melanoma].
February 1997, Deutsche medizinische Wochenschrift (1946),
A I Skene, and A S Bulman, and T R Williams, and J M Thomas, and G Westbury
Isolated limb perfusion with melphalan in the treatment of malignant melanoma.
September 1980, The British journal of surgery,
A I Skene, and A S Bulman, and T R Williams, and J M Thomas, and G Westbury
The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma.
July 1992, British journal of cancer,
A I Skene, and A S Bulman, and T R Williams, and J M Thomas, and G Westbury
Isolated limb perfusion with melphalan for melanoma.
March 2014, Journal of surgical oncology,
A I Skene, and A S Bulman, and T R Williams, and J M Thomas, and G Westbury
[Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor].
January 1996, Langenbecks Archiv fur Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft fur Chirurgie. Kongress,
A I Skene, and A S Bulman, and T R Williams, and J M Thomas, and G Westbury
Current techniques of hyperthermic isolated limb perfusion for malignant melanoma.
January 2000, Surgery today,
A I Skene, and A S Bulman, and T R Williams, and J M Thomas, and G Westbury
Hyperthermic isolated limb perfusion (HILP) in malignant melanoma. Experience with 101 patients.
March 2006, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
A I Skene, and A S Bulman, and T R Williams, and J M Thomas, and G Westbury
Hyperthermic isolated limb perfusion for malignant melanoma: response and survival.
January 1995, World journal of surgery,
A I Skene, and A S Bulman, and T R Williams, and J M Thomas, and G Westbury
A comparison of dosimetric methods in isolated limb perfusion with melphalan for malignant melanoma of the lower extremity.
November 1996, European journal of cancer (Oxford, England : 1990),
Copied contents to your clipboard!